Health ❯ Medicine ❯ Pharmacology ❯ Weight Loss

GLP-1 Agonists

Lancet Trial: Lilly’s Oral GLP-1 Pill Delivers About 10% Weight Loss Over 72 Weeks

The once-daily small molecule is presented as a needle-free option requiring no refrigeration or food‑timing rules.

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research